Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
View Full List
My Watchlist
Create Watchlist
Top Indices
DJI
Nasdaq Composite
SPX
My Portfolio
BioSig Technologies, Inc. - Common Stock
(NQ:
BSGM
)
10.41
+0.76 (+7.88%)
Streaming Delayed Price
Updated: 1:00 PM EDT, Jul 3, 2025
Add to My Watchlist
Quote
Overview
Detailed Quote
Charting
Historical Prices
News
All News
News Headlines
Press Releases
Research
Quarterly Reports
Insider Filings
Other Filings
Press Releases about BioSig Technologies, Inc. - Common Stock
< Previous
1
2
3
Next >
BioSig & Streamex Appoint Parcl Co-Founders Trevor Bacon and Kellan Grenier as Strategic Advisors
June 09, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig & Streamex Appoint Co-Founder of the Osisko Group & Mining Visionary, Sean Roosen as Strategic Advisor
June 04, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates LNSR, ICAD, BSGM, SSBK on Behalf of Shareholders
June 03, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BSGM, SGN, HLGN on Behalf of Shareholders
May 31, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
BIOSIG TECHNOLOGIES INVESTOR ALERT by the Former Attorney General of Louisiana: Kahn Swick & Foti, LLC Investigates Merger of BioSig Technologies, Inc. - BSGM
May 31, 2025
From
Kahn Swick & Foti, LLC
Via
Business Wire
SHAREHOLDER INVESTIGATION: Halper Sadeh LLC Investigates BSGM and TASK on Behalf of Shareholders
May 29, 2025
From
Halper Sadeh LLC
Via
GlobeNewswire
CORRECTION: Streamex and BioSig Appoint Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer (CIO)
May 28, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Appoints Former OppenheimerFunds and Wafra Inc Executive, Mitch Williams, CFA, as Chief Investment Officer
May 28, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
Streamex and BioSig Announce the Successful Closing of Share Exchange Transaction and Executive Leadership Changes Bringing a First-Mover Real World Asset Tokenization Company to the Nasdaq
May 28, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BSGM Stock Alert: Halper Sadeh LLC Is Investigating Whether the Merger of BioSig Technologies, Inc. Is Fair to Shareholders
May 26, 2025
From
Halper Sadeh LLC
Via
Business Wire
BioSig Technologies, Inc. Signs Definitive Share Exchange Agreement with Streamex Exchange Corp. to Launch First-Mover Real-World Asset (RWA) Tokenization Company Bringing Commodity Markets On-Chain.
May 23, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BRODSKY & SMITH SHAREHOLDER UPDATE: Notifying Investors of the Following Investigations: Skechers U.S.A., Inc. (NYSE - SKX), BioSig Technologies, Inc. (Nasdaq – BSGM), Coeptis Therapeutics Holdings, Inc. (Nasdaq – COEP), Pacific Premier Bancorp, Inc.
May 05, 2025
From
Brodsky & Smith LLC
Via
GlobeNewswire
BioSig Enters into an LOI to Merge with Streamex Exchange Corp. Creating a Publicly Listed Real-World Asset Tokenization Company Led by Seasoned Industry Executives
May 05, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Confirms Full Compliance with Nasdaq Requirements for Continued Listing on The Nasdaq Capital Market
March 26, 2025
From
BioSig Technologies, Inc.
Via
GlobeNewswire
OTC Markets Group Announces Quarterly Index Performance and Rebalancing
January 22, 2025
From
OTC Markets
Via
GlobeNewswire
BioSig Regains Compliance with Nasdaq’s Minimum Bid Price Requirement
November 13, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies’ Common Stock to Resume Trading on the NASDAQ Exchange, Wednesday, October 23, 2024 After Its Successful Appeal to the NASDAQ Panel
October 22, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Announces Intent to Acquire the Assets of Neuro-Kinesis Corporation
July 31, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Improves Balance Sheet, Announces Reduction in Outstanding Payables during Q2 2024
July 25, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Appoints Mr. Ferdinand Groenewald to Position of Interim Chief Financial Officer and Principal Accounting Officer
June 10, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Closing of $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces $3 Million Registered Direct Offering Priced At-the-Market Under Nasdaq Rules
May 30, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies Chief Executive Officer Mr. Anthony Amato Issues the Following Letter to Shareholders
May 21, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies, Inc. Announces New Appointments to its Now Fully Constituted Board of Directors, which is Comprised of 5 Board Members, 3 Independent
May 03, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Technologies, Inc. Appoints Mr. Anthony Amato to Position of Chief Executive Officer, Effective Immediately
April 30, 2024
Mr. Amato will also serve on the Company’s Board of Directors
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Engages Consulting Firm for Business Model Strategies
April 04, 2024
BAIPC will work to deploy a series of solutions to transform BioSig’s future course
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Reduction of its Workforce
February 20, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig’s PURE EP™ Platform with New Near Field Tracking Algorithm Surpasses 100 Patient Cases
February 06, 2024
Company sees clinical adoption and usage of its novel Near Field Tracking algorithm, proven to reduce ablation time by approximately 66%.
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Reverse Stock Split
January 31, 2024
Common Stock Will Begin Trading on Split-Adjusted Basis on February 2, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
BioSig Announces Cost Reductions to Improve its Financial Standing and Shifts its Core Strategy
January 30, 2024
From
BioSig Technologies, Inc.
Via
GlobeNewswire
< Previous
1
2
3
Next >
Stock Quote API & Stock News API supplied by
www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy
and
Terms Of Service
.